Toronto, ON – Researchers led by Dr. Helen McNeill at the Lunenfeld-Tanenbaum Research Institute have revealed an exciting and unusual biochemical connection. Their discovery has implications for diseases linked to mitochondria, which are the primary sources of energy production within our cells.
Dr. McNeill’s team has an international reputation for their work in understanding how cells become organized into tissues and how growth is regulated during development. The group focuses on mutations in the fat (ft) gene. The protein product of this gene, called ‘Fat’, acts at the cell membrane to promote adhesion and communication between cells. Mutations in ft can cause cells to overgrow and become tumours. This occurs partially through the Hippo pathway, a pathway that is frequently activated in cancers such as liver, breast, ovarian and sarcomas.
Fat proteins are typically thought to work at the cell surface, but the team’s paper, published today in the journal Cell, uncovers for the first time that a piece of the Fat protein is actually processed and delivered into the mitochondria where it influences the energy status of the cell. Importantly, when this particular component is missing, the energy generating pipeline inside mitochondria become destabilized, leading to loss of energy production.
“We were amazed to find that Fat proteins interact directly with mitochondria in a cell, regulating the cell’s metabolism,” says Dr. McNeill, a senior investigator at the Lunenfeld-Tanenbaum Research Institute and a professor in the Department of Molecular Genetics at the University of Toronto. “We still want to know how a cell knows when to release the Fat protein into mitochondria, but for now, this new linkage opens up a whole new way of thinking about how cellular energy is controlled as well as new ideas about how to shut down cancer cell growth.”
When mitochondria stop working properly, cells no longer have an efficient energy source. Instead, cells will switch to glycolysis to produce the energy they require, known as the Warburg effect. Similarly, tumour cells have glycolytic rates up to 200 times higher compared to normal cells. Since the mitochondria is responsible for producing energy for essential cellular functions, problems with mitochondria can also lead to illnesses such as Type 2 diabetes, Parkinson’s disease, heart disease, stroke, and Alzheimer’s disease.
The research team has been evaluating their discovery in fruit flies, since they serve as a powerful model for human mitochondria. Their next steps are to test these findings on human cells.
“This new finding that links the cell membrane to mitochondrial function is important since it defines a totally new mechanism of cellular regulation,” says Yonit Tsatskis, a research associate in Dr. McNeill’s lab.
“When I started this project I had expected to learn a bit about eye development in fruit flies, but I had no idea that it would lead me to work on mitochondrial and metabolic defects in tumour cells,” says co-author Anson Sing, a Ph.D. candidate in Dr. McNeill’s lab. “That’s what’s great about working in research, making new discoveries and connections. It’s exciting to be a part of that scientific process.”
The team are investigating the specific role the ft gene plays with the hope of identifying new treatment targets for cancer and other diseases related to Fat malfunction.
The study is “The Atypical Cadherin Fat Directly Regulates Mitochondrial Function and Metabolic State,” published in Cell on September 11, 2014. Authors are Anson Sing, Yonit Tsatskis, Lacramioara Fabian, Ian Hester, Robyn Rosenfeld, Mauro Serricchio, Norman Yau, Ma¨lis Bietenhader, Riya Shanbhag, Andrea Jurisicova, Julie A. Brill, G. Angus McQuibban, and Helen McNeill, and the study was funded by the Canadian Institutes of Health Research.